UnknownPhase 3NCT02036229
Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis
Studying Demodicidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rabin Medical Center
- Principal Investigator
- Rina Segal, MDRabin Medical Center
- Intervention
- ivermectin cream 0.5%(drug)
- Enrollment
- 50 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2016
Study locations (1)
- RabinMC, Dermatology dept., Petah Tikva, Israel
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02036229 on ClinicalTrials.gov